The operation of CURES complies with all applicable federal and state privacy and security laws and regulations. CURES is committed to the reduction of prescription drug abuse and diversion without affecting legitimate medical practice or patient care. Controlled Substance Utilization Review and Evaluation System California’s Prescription Drug Monitoring ProgramĬURES (Controlled Substance Utilization Review and Evaluation System) is a database of Schedule II, Schedule III, Schedule IV and Schedule V controlled substance prescriptions dispensed in California serving the public health, regulatory oversight agencies, and law enforcement. The second sample Delegate Agreement demonstrates an agreement between one Authorizing User and multiple Delegates.ĭetailed information concerning Delegate eligibility and Delegate Agreement requirements are described in DOJ’s October 14, 2022, bulletin entitled, New Features and Requirements for Expanded Delegate Access. The first sample Delegate Agreement demonstrates an agreement between one Authorizing User and one Delegate. For detailed information view the Quick Reference Guide.ĭOJ has also created two sample Delegate Agreements. The Department of Justice (DOJ) has created a Quick Reference Guide that details how to establish and activate a Delegate in the optimized CURES, along with questions and answers. To continue using Delegates after April 11, 2022, new Delegate associations must be established. The optimized CURES includes expanded Delegate functionality, which allows Delegates to directly access data in CURES.Īll prior Delegate associations were disabled upon the release of the optimized CURES on April 11, 2022. New Requirements for Expanded Delegate Functionality
0 kommentar(er)
